Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi*, William Jacot, Toshinari Yamashita, Joohyuk Sohn, Maria Vidal, Eriko Tokunaga, Junji Tsurutani, Naoto T. Ueno, Aleix Prat, Yee Soo Chae, Keun Seok Lee, Naoki Niikura, Yeon Hee Park, Binghe Xu, Xiaojia Wang, Miguel Gil-Gil, Wei Li, Jean Yves Pierga, Seock Ah Im, Halle C.F. MooreHope S. Rugo, Rinat Yerushalmi, Flora Zagouri, Andrea Gombos, Sung Bae Kim, Qiang Liu, Ting Luo, Cristina Saura, Peter Schmid, Tao Sun, Dhiraj Gambhire, Lotus Yung, Yibin Wang, Jasmeet Singh, Patrik Vitazka, Gerold Meinhardt, Nadia Harbeck, David A. Cameron

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

922 Scopus citations

Fingerprint

Dive into the research topics of 'Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences